How have N4P shares performed in 2024?

N4 Pharma's stock was trading at GBX 0.85 at the beginning of the year. Since then, N4P stock has increased by 2.5% and is now trading at GBX 0.87. View the best growth stocks for 2024 here .

How were N4 Pharma's earnings last quarter?

N4 Pharma Plc (LON:N4P) posted its quarterly earnings results on Thursday, September, 17th. The company reported ($0.48) earnings per share (EPS) for the quarter.

What other stocks do shareholders of N4 Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other N4 Pharma investors own include Intercede Group (IGP) , Medpace (MEDP) , Regeneron Pharmaceuticals (REGN) , Sirius Minerals (SXX) , SolGold (SOLG) , Reach (RCH) , Petra Diamonds (PDL) , Interserve (IRV) , Cornerstone Capital Resources (CGP) and Bushveld Minerals (BMN) .

How do I buy shares of N4 Pharma?

Shares of N4P stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:N4P

N4 Pharma (N4P) Share Price, News & Analysis

→ Your Next Portfolio Star: Revealing 2024's Top Stock Pick (From Darwin) (Ad)

Free N4P Stock Alerts

GBX 0.87

+0.02 (+2.47%)

(As of 03:40 PM ET)

Compare

Today's Range: 0.80
▼
0.90
50-Day Range: 0.60
▼
0.85
52-Week Range: 0.60
▼
2.30

Volume: 119,308 shs
Average Volume: 1.22 million shs
Market Capitalization: £2.34 million

P/E Ratio: N/A
Dividend Yield: 3.12%
Price Target: N/A

Stock Analysis Chart Competitors

Get N4 Pharma alerts:

Ad Tips4Traders

Uncover this 2024 Hidden Gem

Exclusive Report: Uncover a Hidden Investment Gem We’re excited to share a special report on one exceptional, publicly traded company. This company has achieved a remarkable 22+% just this year, outperforming the market and revealing the potential for significant gains.

[Click here to subscribe] and elevate your trading today.

About N4 Pharma Stock (LON:N4P)

N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.

N4P Stock Price History

30 days | 90 days | 365 days | Advanced Chart

N4P Stock News Headlines

January 24, 2024 | lse.co.uk

N4 Pharma Plc Share Chat

September 28, 2023 | marketwatch.com

N4 Pharma Acquires Major Stake in Nanogenics Through Discounted Share Placing; Shares Fall

April 19, 2024 | DTI (Ad)

Don’t expose yourself to stocks during the week

The S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.

July 25, 2023 | marketwatch.com

N4 Pharma Shares Rise After Further Nuvec Patent Granted in US

April 26, 2023 | marketwatch.com

N4 Pharma Shares Rise on Development of Nuvec Test

March 9, 2023 | marketwatch.com

N4 Pharma's Pretax Loss Narrowed in 2022 on Lower R&D Costs

February 26, 2023 | seekingalpha.com

Microcap Timber Pharmaceuticals up 46% on orphan drug designation for skin disorder drug

January 18, 2023 | marketwatch.com

N4 Pharma Shares Rise on Positive Nuvec Oral Application Results

April 19, 2024 | DTI (Ad)

Don’t expose yourself to stocks during the week

November 1, 2022 | marketwatch.com

N4 Pharma Enhances Nuvec's Application Claims in Bid to Gain Patent Protection

October 11, 2022 | finance.yahoo.com

Institutions profited after N4 Pharma Plc's (LON:N4P) market cap rose UK£2.9m last week butindividual investors profited the most

October 4, 2022 | marketwatch.com

N4 Pharma Shares Rise on Successful Testing of Nuvec, Vaccine System

September 29, 2022 | marketwatch.com

N4 Pharma Narrows 1H Loss by Controlling Expenditure; Shares Rise

September 3, 2022 | uk.investing.com

FTSE South Africa Technical Analysis

August 13, 2022 | finance.yahoo.com

N4 Pharma Plc (N4P.L)

July 15, 2022 | marketwatch.com

N4 Pharma Shares Rise on Further Nuvec Progress

June 13, 2022 | marketwatch.com

N4 Pharma Shares Rise on Positive Results for Nuvec Delivery System

March 31, 2022 | finance.yahoo.com

Beroni Group Announces Appointment of Dr. John Chiplin to Board of Directors

January 31, 2022 | marketwatch.com

N4 Pharma Says Nuvec Granted Patents in U.S., China

January 25, 2022 | marketwatch.com

N4 Pharma to Work on Nuvec With Medicines Discovery Catapult Following Encouraging Results

December 13, 2021 | marketwatch.com

N4 Pharma to Focus Resources on Advancing Gene Therapy Work

August 30, 2021 | finance.yahoo.com

We Think N4 Pharma (LON:N4P) Can Afford To Drive Business Growth

August 24, 2021 | marketwatch.com

N4 Pharma Says Nuvec Studies Are Progressing Well

See More Headlines

Receive N4P Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for N4 Pharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 9/17/2020
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Current Symbol: LON:N4P
CUSIP: N/A
CIK: N/A
Web: www.n4pharma.com
Phone: +44-1332-690061
Fax: N/A
Employees: 5
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: £-1,030,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -65.34%
Return on Assets: -43.80%

Debt

Debt-to-Equity Ratio: 1.62
Current Ratio: 27.88
Quick Ratio: 7.28

Sales & Book Value

Annual Sales: £23,524.00
Price / Sales: 94.49
Cash Flow: GBX 0.37 per share
Price / Cash Flow: 2.25
Book Value: GBX 1 per share
Price / Book: 0.83

Miscellaneous

Outstanding Shares: 268,780,000
Free Float: N/A
Market Cap: £2.22 million
Optionable: Not Optionable
Beta: -0.03

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Mr. Nigel James Theobald (Age 60)
Founder, CEO & Executive Director
Comp: $77.5k
Dr. David Templeton (Age 72)
Executive Director & Technical Director
Comp: $46.5k
Mr. Luke Sebastian Cairns (Age 46)
Executive Director
Comp: $41.33k
Rob Harris
Head of CMC Development
Dr. Andrew Leishman
Consultant

Key Competitors

View All Competitors

N4P Stock Analysis - Frequently Asked Questions

How have N4P shares performed in 2024?: N4 Pharma's stock was trading at GBX 0.85 at the beginning of the year. Since then, N4P stock has increased by 2.5% and is now trading at GBX 0.87.
View the best growth stocks for 2024 here.
How were N4 Pharma's earnings last quarter?: N4 Pharma Plc (LON:N4P) posted its quarterly earnings results on Thursday, September, 17th. The company reported ($0.48) earnings per share (EPS) for the quarter.
What other stocks do shareholders of N4 Pharma own?: Based on aggregate information from My MarketBeat watchlists, some companies that other N4 Pharma investors own include Intercede Group (IGP), Medpace (MEDP), Regeneron Pharmaceuticals (REGN), Sirius Minerals (SXX), SolGold (SOLG), Reach (RCH), Petra Diamonds (PDL), Interserve (IRV), Cornerstone Capital Resources (CGP) and Bushveld Minerals (BMN).
How do I buy shares of N4 Pharma?: Shares of N4P stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:N4P) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial